Com_COV_vaccine_trials.mp4 211,56MB
1000 Titel
  • Com-COV 'mix and match' vaccine trial delivery
1000 Titelzusatz
  • Com-COV vaccine trials - VACCELERATE webinar September 15 2021
1000 Titelzusatz weitere
  • Oxford Vaccine Group, VACCELERATE webinar, Wednesday 15th June 2021
1000 Verantwortlich
  • NHR - Oxford Biomedical Research Centre, HM Government, CEPI, Public Health England, oxford vaccine group, University of Oxford, NISEC, COM-COV - Comparing COVID-19 Vaccine Schedule Combinations, COV-BOOST - Evaluating COVID-19 vaccine boosters, University Hospital Southampton ; Professor Matthew Snape ; VACCELERATE
1000 Beteiligung
VACCELERATE (Projekt) (Herausgeber/in) |
1000 Autor/in
  1. VACCELERATE (Projekt) |
1000 Katalog Id
  • HT021192768
1000 Erscheinungsort Köln
1000 Erscheinungsjahr 2021
1000 Art der Datei
1000 Publikationstyp
  1. Video |
  2. Sonstige |
1000 FRL-Sammlung
1000 Sprache der Publikation
1000 Abstract/Summary
  • The Oxford Vaccine Group’s vaccine trials have delivered important data on the combination of approved COVID-19 vaccines for first and second immunization doses. The Com-Cov1 study investigates the safety and immune responses of COVID-19 vaccines that are potentially to be deployed in the UK. The Com-COV2 study follows on and works in parallel with the Com-COV1 approach to answer the same questions, but involving different vaccines. Both studies include persons aged 50 and over. One important question is that of ‘mixed’ schedules. This is important, as being able to use different vaccines in this way creates a more flexible immunization program. COM-COV is led by Prof. Matthew Snape and delivered by a network of trial sites across the UK. VACCELERATE, the EU funded clinical research network for the coordination & conduct of COVID-19 vaccine trials is looking forward to host this webinar. Prof. Matthew Snape and his colleague Emma Plested will present the studies and their goals and give insights into the results on vaccination reactions, effectiveness and the time gap between the doses.
1000 Sacherschließung
  1. COVID-19
ddc 610 Medizin und Gesundheit
1000 DOI 10.4126/FRL01-006431119 |
1000 Verlagsversion
1000 Dateien
  1. Com-COV vaccine trials
1000 Umfang
  • 1 Online-Ressource (1 Videodatei, Lauflänge: 01:00:15)
1000 Schlagwörter
1000 Objektart monograph
1000 Beschrieben durch
1000 @id frl:6431119.rdf
1000 Erstellt am 2022-01-13T14:30:07.112+0100
1000 Erstellt von 25
1000 beschreibt frl:6431119
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Mon Jan 17 05:04:46 CET 2022
1000 Objekt bearb. Fri Jan 14 08:16:34 CET 2022
1000 ähnlich zu
1000 Vgl. frl:6431119
1000 Oai Id
  1. |
1000 Identisch zu
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Beschrieben durch
1000 Bestand
1000 Lobid

View source